The protein advice is not wrong — it is just radically incomplete. Women who hit 100 grams of protein every single day, who meticulously tracked their intake, who did everything the guidance said, still lost a third of their hair. On the forums they fill with frustration: doctors throwing "eat more protein" at a problem that protein simply does not fix.

Here is what protein cannot address: when fat breaks down rapidly, the oestrogen stored in that fat tissue is released — then depleted. That sudden hormonal shift pushes follicles into a resting phase at the same time the caloric stress signals your body to cut non-essential functions. Your scalp is dealing with two converging pressures simultaneously. Protein solves neither of them.

For women with no underlying hormonal issue, GLP-1-triggered shedding does eventually resolve. For women in perimenopause or menopause — which describes a significant portion of Ozempic and Mounjaro users — the shed lands on top of follicle miniaturisation that was already quietly underway. In that scenario, waiting is not a strategy. It is a gamble.

Follicles that go dormant and receive no support for six, nine, twelve months do not always return. The window to wake them is not infinite. Most women who found their way to a treatment that worked say the same thing: I wish I had started sooner instead of waiting to see if it resolved by itself.

The instinct is to reach for biotin capsules, hair vitamins, collagen powders. The problem is the route they have to take. When you are on a GLP-1, your stomach empties more slowly, your appetite is suppressed, and you are eating significantly less overall. Sending an oral supplement through that compromised absorption system — through the liver, dispersed through the bloodstream — and hoping the fraction that survives reaches your scalp follicles is exactly as inefficient as it sounds.

Follicle problems are solved at the follicle. Applied topically to the scalp, the actives arrive directly — no digestive system competition, no liver metabolism, no dilution across every organ between mouth and hair root. This is why scalp-targeted delivery consistently outperforms oral delivery for hair-specific outcomes.

This is the cruellest part of GLP-1 hair loss. You worked incredibly hard to get here. The weight loss is working. You feel better than you have in years — your joints, your energy, your relationship with food. And now you are sitting in the shower wondering if you should give all of that back to save what is left of your hair.

What no one tells you: the shedding does not stop the moment you put the pen down. The follicles that entered the resting phase continue that cycle for 3 to 6 months after stopping — regardless. You lose the medication's benefits. The hair keeps falling anyway. The problem is not the medication. The problem is what the medication is not addressing at the follicle level — and that can be addressed without touching the medication at all.

Minoxidil gets passed around GLP-1 communities because it is the one clinically recognised name people recognise. It is also a drug you will be on for the rest of your life — because stopping it triggers a rebound shed that many GLP-1 users cannot afford on top of the one they are already managing.

The GLP-1 shed is not androgenic alopecia. It is a hormonally triggered, stress-induced follicle disruption with a recoverable window. Committing to a pharmaceutical treadmill before trying a scalp-level, hormone-aware alternative is a choice most women regret once they understand it. Many find that addressing DHT at the follicle and restoring oestrogen-depleted microcirculation topically — without a prescription — is sufficient to stabilise and reverse the shed.

The GLP-1 forums are full of frantic rotation: rosemary oil this week, a new scalp serum from Amazon the next, a biotin shampoo someone mentioned in a thread. Every switch feels like action. Every switch also resets the clock to zero.

Follicles that have entered a telogen shed and begun miniaturising do not respond in two weeks. They respond in 8 to 12. Every time you abandon a product, you guarantee you will never know if it was working. The women who see results pick one scalp-level treatment, give it a full 12 weeks, and measure the shower drain objectively. That discipline is the difference between recovery and a bathroom shelf full of things that "didn't work" — that simply were never given enough time.

There is an unspoken consensus in GLP-1 communities that hair loss is the toll you pay. You wanted the weight loss — the hair is what you traded for it. Accept it gracefully and be grateful for what you got.

That is not a trade you are required to accept. You deserved the weight loss. You also deserve to keep your hair. The two are not in conflict — they require addressing different layers of the same disruption, and the hair layer has a very specific, very targeted solution.

Mellenza Hair Growth Spray is how thousands of women on GLP-1 medications are quietly addressing it. 30 seconds in the evening, applied directly to the scalp, targeting the five mechanisms the GLP-1-hormonal convergence disrupts:

Caffeine interrupts local DHT activity at the follicle bulb — the same androgen pressure that intensifies when oestrogen depletes rapidly during fat loss. Polygonum multiflorum supports follicle proliferation in follicles that have gone dormant under the stress shed. Arginine restores the microcirculation that oestrogen depletion narrows around the follicle. Biotin, delivered topically, arrives directly at the follicle without competing with a GLP-1-suppressed digestive system. Ginger extract supports the anagen phase and drives the other actives deeper into the follicle environment.

No pills to add to an already suppressed appetite. No prescription. No minoxidil dependency. 90% of women in our 90-day study said the evening ritual stuck — because 30 seconds before bed is a commitment anyone can keep.